CINECA IRIS Institutional Research Information System

RAGUSA, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.414
EU - Europa 1.302
AS - Asia 388
AF - Africa 82
OC - Oceania 6
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.198
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.391
IT - Italia 684
SE - Svezia 341
SG - Singapore 129
BG - Bulgaria 110
CN - Cina 104
VN - Vietnam 79
DE - Germania 55
CI - Costa d'Avorio 39
GB - Regno Unito 26
IQ - Iraq 23
CA - Canada 21
HK - Hong Kong 20
NG - Nigeria 20
SN - Senegal 20
IN - India 18
RU - Federazione Russa 17
PL - Polonia 11
AT - Austria 10
FR - Francia 8
IE - Irlanda 8
NL - Olanda 8
AU - Australia 5
CZ - Repubblica Ceca 5
CH - Svizzera 4
TR - Turchia 4
UA - Ucraina 4
BE - Belgio 3
FI - Finlandia 3
IR - Iran 3
JP - Giappone 3
EC - Ecuador 2
ES - Italia 2
EU - Europa 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
RO - Romania 1
SC - Seychelles 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.198
Salva come PNG Salva come JPEG
Città #
Fairfield 400
Ashburn 215
Woodbridge 205
Chandler 179
Seattle 169
Milan 166
Pisa 150
Cambridge 149
Houston 138
Wilmington 132
Serra 124
Sofia 110
New York 76
Boardman 72
Princeton 72
Ann Arbor 58
Singapore 54
Lawrence 46
Medford 42
Abidjan 39
Florence 39
Beijing 36
Dong Ket 27
Boulder 26
Redwood City 23
San Diego 23
Bremen 20
Dakar 20
Hong Kong 20
Rome 20
Des Moines 19
Frankfurt am Main 18
Lagos 18
Livorno 18
Sulaymaniyah 18
Ogden 16
Ottawa 16
Nanjing 15
Carrara 13
Los Angeles 13
Dearborn 12
Washington 12
Norwalk 11
Vienna 10
Warsaw 9
Dublin 8
Hyderabad 8
London 8
Amsterdam 6
Guangzhou 6
Chengdu 5
Massa 5
Changsha 4
Dallas 4
Fremont 4
Kilburn 4
Naples 4
Phoenix 4
San Francisco 4
Serpukhov 4
Shenyang 4
St Petersburg 4
Tianjin 4
Agliana 3
Bern 3
Brussels 3
Jiaxing 3
Kent 3
Lucca 3
Minneapolis 3
Pomezia 3
Absecon 2
Alexandria 2
Basra 2
Bedford 2
Boston 2
Cascina 2
Castano Primo 2
Cavriglia 2
Gabbro 2
Gunzenhausen 2
Hebei 2
Hefei 2
Islington 2
Kunming 2
Lancaster 2
Melbourne 2
Nanchang 2
Nasiriyah 2
Palermo 2
Prague 2
Sant'Anastasia 2
Siena 2
Thornhill 2
Wuhan 2
Zhengzhou 2
Acton 1
Almaty 1
Altopascio 1
Ardabil 1
Totale 3.236
Salva come PNG Salva come JPEG
Nome #
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 142
Sunitinib in the treatment of thyroid cancer 130
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 123
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 123
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 119
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 114
Novel treatment options for anaplastic thyroid cancer 102
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 102
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 102
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 101
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 100
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 97
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 94
Novel therapies for thyroid autoimmune diseases: An update 94
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide 93
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 93
Molecular testing in the diagnosis of differentiated thyroid carcinomas 92
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 91
Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis 90
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy 90
New insight in endocrine-related adverse events associated to immune checkpoint blockade 86
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 85
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 84
Recent advances in precision medicine for the treatment of anaplastic thyroid cancer 84
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 84
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 84
Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy 84
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 84
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 83
Chemokines in hyperthyroidism 80
Novel treatments for anaplastic thyroid carcinoma 80
The protective effect of myo-inositol on human thyrocytes 79
Immune and inflammatory cells in thyroid cancer microenvironment 77
Th1 chemokines in autoimmune endocrine disorders 76
null 75
Nutraceuticals in thyroidology: A review of in vitro, and in vivo animal studies 73
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 71
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 65
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies 63
Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes 62
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 62
Thyroid autoimmune disorders and cancer 58
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases 58
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 54
Endocrine disruptors and thyroid autoimmunity 52
L-T4 Therapy in Enteric Malabsorptive Disorders 48
Precision Medicine in Graves’ Disease and Ophthalmopathy 47
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 44
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 38
Chemokines in thyroid autoimmunity 37
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer 36
Teprotumumab for the treatment of thyroid eye disease 34
Molecular features of aggressive thyroid cancer 30
Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis 30
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 28
Myoinositol in Autoimmune Thyroiditis 27
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series 26
Thyroid Metastasis from Primary Breast Cancer 25
Thyroid Autoimmunity and SARS-CoV-2 Infection 19
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 16
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review 15
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review 12
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 10
Hypothyroidism and metabolic cardiovascular disease 7
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose 6
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In Vitro 6
Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer 3
Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity 3
Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study 2
Totale 4.484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.884
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020868 0 0 83 50 65 90 104 112 195 73 59 37
2020/2021492 38 54 51 12 23 24 18 53 34 61 28 96
2021/2022715 13 14 28 47 109 92 32 33 67 59 56 165
2022/2023770 118 106 67 37 68 92 34 46 122 5 62 13
2023/2024845 67 78 121 99 123 135 55 24 12 17 39 75
2024/2025268 134 74 60 0 0 0 0 0 0 0 0 0
Totale 4.484